Diamorphine 5mg and 10mg powder used for solution for injection ampoules will remain unavailable until February 2022, Department of Health and Social Care (DHSC) has said in an update.
These injection ampoules are used to treat severe pain associated with surgical procedures, pain in the terminally ill, and to provide relief in acute pulmonary oedema.
Diamorphine 30mg and 100mg ampoules are available, however, the stock is not enough to support an uplift in demand.
Separately, the DHSC has extended the Medicine Supply Notification for Kolanticon gel, which is expected to remain unavailable until October 2022.
The medication is used to treat treatment stomach related complaints such as gastro-intestinal disorders.
Earlier, Kolanticon gel was expected to remain out of stock until January 2022.